alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
SUBSIDIARIES OF THE REGISTRANT

Set forth below is a list of certain of the Registrants subsidiaries. Such subsidiaries are incorporated or organized in the jurisdictions indicated. Revlon Consumer Products Corporation is wholly owned by the Registrant. Each of the other listed subsidiaries is wholly owned by Revlon Consumer Products Corporation, directly or indirectly, and all listed subsidiaries are included in the Registrants consolidated financial statements. The names of the Registrants remaining subsidiaries, if any, which may have been omitted from the following list, considered in the aggregate as a single subsidiary, would not constitute a significant subsidiary.

Domestic Subsidiaries

Almay, Inc., a Delaware corporation

Charles of the Ritz Group Ltd., a Delaware corporation

Charles Revson Inc., a New York corporation

Cosmetics & More Inc., a Delaware corporation

North America Revsale Inc., a New York corporation

PPI Two Corporation, a Delaware corporation

Revlon Consumer Corp., a Delaware corporation

Revlon Consumer Products Corporation, a Delaware corporation

Revlon Development Corp., a Delaware corporation

Revlon Government Sales, Inc., a Delaware corporation

Revlon International Corporation, a Delaware corporation

Revlon Products Corp., a Delaware corporation

Revlon Real Estate Corporation, a Delaware corporation

RIROS Corporation, a New York corporation

RIROS Group Inc., a Delaware corporation

Foreign Subsidiaries

ACN 000 189 186 Pty. Limited (Australia)

CEIL  Comercio e Distribuidora Ltda. (Brazil)

Cendico B.V. (Netherlands)

Deutsche Revlon GmbH (Germany)

European Beauty Products S.L. (Spain)

Européenne de Produits de Beauté S.A.S. (France)

New Revlon Argentina S.A. (Argentina)

Productos Cosmeticos de Revlon, S.A. (Guatemala)

Promethean Insurance Limited (Bermuda)

REMEA 2 B.V. (Netherlands)

Revlon A.B. (Sweden)

Revlon Australia Pty Limited (Australia)

Revlon Beauty Products, S.L. (Spain)

Revlon B.V. (Netherlands)

Revlon Canada Inc. (Canada)

Revlon Chile S.A. (Chile)

Revlon China Holdings Limited (Cayman Islands)

Revlon Europe, Middle East and Africa Ltd. (Bermuda)

Revlon Group Limited (United Kingdom)

Revlon (Hong Kong) Limited (Hong Kong)

Revlon (Israel) Limited (Israel)

Revlon Kabushiki Kaisha (Japan)

Revlon Ltda. (Brazil)

Revlon Manufacturing Ltd. (Bermuda)

Revlon Mauritius Ltd. (Mauritius)

Revlon New Zealand Limited (New Zealand)

Revlon Offshore Limited (Bermuda)

Revlon Overseas Corporation, C.A. (Venezuela)

Revlon Pension Trustee Company (U.K.) Limited (United Kingdom)





---





Revlon (Puerto Rico) Inc. (Puerto Rico)

Revlon Real Estate Kabushiki Kaisha (Japan)

Revlon, S.A. de C.V. (Mexico)

Revlon (Shanghai) Limited (China)

Revlon South Africa (Proprietary) Limited (South Africa)

Revlon S.p.A. (Italy)

Revlon (Suisse) S.A. (Switzerland)

Revlon Taiwan Limited (Taiwan)

S.E.F.A.O., S.A. (Spain)

Shanghai Revstar Cosmetic Marketing Services Limited (China)

YAE Artistic Packings Industry Ltd. (Israel)

YAE Press 2000 (1987) Ltd. (Israel)





---
15 October 1952 

Memrandwn fer: Ths USCia Coordinator ~........,..._- -- =--w;.':" 

Subj: Coronation of :)ueen Elizabeth II, 2 ,June 1953 

lo It is not too early to bring to your attention and to the attention 

of all Board members the fact that it 1vill be impossible to conduct any 

business in London with overseas visitors during May and June of 1953~ 

2o Even today hotel accorrunodat5ons are arranged by this office several 

days in advance to insure that visito:r-s will be adequately, not 

luxuriously~ taken care of~ Today~ transportation out of Engl.and. is 

difficult to, with the Lendon MATS office 3etting only three seats per 

week on the two Frankfurt-Paris~Washington nights,, Of course t.he 

regul.1ir Mi\TS service from Prestwick through Ireland-Newfoundland and 

Nova Scot'ia to Westover is also a'raiL'lble" It seems unlikely that. 

additional military flights will be laid on for the Coronationo 

Commercial transport 9 both sea and afr .t1 is now booked solid in both 

clirections 9 with ~CllJi!: waitin~ lists 9 over the Coronation periodo 

·3u This office vaill be unable to arrange aec:ommodat.ions ar transportation 

for May and June 1953» or to arrange for seats along the Coronation route, 

Official visits should conclude by 1 ~4ay 1953 and not commence again until 

mid-July 19530 Probably the whole summer following the Coronation will 

f:i:nd this Island innwidated with tourists making accommodations both 

difficult and expensive. 

4o Additional da.ta.9 to assist t.hooe able to afford the expense of a 

parsona.1 visiti> is contained in the attflched· O.."'pies ~t." a. letter from the 

ArlIJll Attache~ LonUon» Fngland, 

Copy to: 

Air httache 9 London 

Arrn.1 Attachej London 

Chief 9 i\.SA(E) 

Chier. AFSA FA (Europe) 

C()9 6910th Securit~ Group 

Pl?w\\~ B, PULLWG 

ColCJnel 9 USAF 

Senior UaSo Liaison Officer 

Declassified and approved for release by NSA on 04-09-2014 pursuant to E. 0. 1352B
**Exhibit 32.2****Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**I, Michael J. McCann, Chief Financial Officer, PHI, Inc. (the “Company”), certify, pursuant toSection 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that: 1. the Quarterly Report on Form 10-Q for the period ended March 31, 2008 as filedwith the Securities and Exchange Commission on the date hereof (the “Report”) fullycomplies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Actof 1934; and  2. the information contained in the Report fairly presents, in all materialrespects, the financial condition and results of operations of the Company.Date: May 8, 2008         By:                          /s/ Michael J. McCann    Michael J. McCann    Chief Financial Officer
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             APR-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                              67
<SECURITIES>                                         0
<RECEIVABLES>                                      328
<ALLOWANCES>                                         0
<INVENTORY>                                        443
<CURRENT-ASSETS>                                    14
<PP&E>                                             206
<DEPRECIATION>                                      45
<TOTAL-ASSETS>                                    2524
<CURRENT-LIABILITIES>                              700
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           168
<OTHER-SE>                                      11,225
<TOTAL-LIABILITY-AND-EQUITY>                      2524
<SALES>                                            440
<TOTAL-REVENUES>                                   440
<CGS>                                              186
<TOTAL-COSTS>                                      000
<OTHER-EXPENSES>                                   751
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   4
<INCOME-PRETAX>                                  (501)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              (501)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (501)
<EPS-BASIC>                                    (.03)
<EPS-DILUTED>                                    (.03)


</TABLE>
**Exhibit 23.1**

 

**CONSENT OF INDEPENDENT ACCOUNTANTS**

 

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (File Nos.333-54042, 333-45732, 333-39860, 333-36640, 333-36618, 33-50860, 33-50862, 33-50864, 33-57734, 33-78804, 33-92312, 33-95288, 333-22631, 333-26857, 333-28745, 333-28675, 333-40671, 333-46259, 333-78553, 333-78551, 333-60764, 333-53705, 333-53707 and333-87984) of ePresence, Inc. of our report dated February 1, 2001 relating to the financial statements, which appears in the Annual Report to Shareholders, which is incorporated in this Annual Report on Form 10-K. We also consent to theincorporation by reference of our report dated February 1, 2001 relating to the financial statement schedule, which appears in this Form 10-K. 

 

/s/  PricewaterhouseCoopers LLP 

March 28, 2003
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 98-6164

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

NIGEL NICHOLAS DOUGLAS, a/k/a Junior,

Defendant - Appellant.

Appeal from the United States District Court for the Eastern District of Virginia, at Norfolk. Henry C. Morgan, Jr., District

Judge. (CR-93-131, CA-97-806-2)

Submitted: May 14, 1998 Decided: June 2, 1998

Before WIDENER and MICHAEL, Circuit Judges, and BUTZNER, Senior

Circuit Judge.

Dismissed by unpublished per curiam opinion.

Nigel Nicholas Douglas, Appellant Pro Se. Robert Joseph Seidel,

Jr., Assistant United States Attorney, Arenda L. Wright Allen,

Assistant United States Attorney, Kevin Michael Comstock, OFFICE OF

THE UNITED STATES ATTORNEY, Norfolk, Virginia, for Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Appellant appeals the district court's order dismissing only

some of the claims alleged in his motion under 28 U.S.C. § 2255

(West 1994 & Supp. 1998). We dismiss the appeal for lack of jurisdiction because the order is not appealable. This court may exercise jurisdiction only over final orders, 28 U.S.C. § 1291 (1994),

and certain interlocutory and collateral orders, 28 U.S.C. § 1292

(1994); Fed. R. Civ. P. 54(b); Cohen v. Beneficial Indus. Loan

Corp., 337 U.S. 541 (1949). The order here appealed is neither a

final order nor an appealable interlocutory or collateral order.

We deny a certificate of appealability, deny the motions to

appoint counsel and stay the appeal, and dismiss the appeal as

interlocutory. We dispense with oral argument because the facts and

legal contentions are adequately presented in the materials before

the court and argument would not aid the decisional process.

DISMISSED
ex10two.htm


     

     

     

    
      

      

    

    
 

    Exhibit
10.2

    


    HALL
TEES, INC.

    


    ADVANCES
AGREEMENT

    


    This
agreement dated September 30, 2007, between Hall Tees and Promotions, LLC,
(“Halltees”) and William Lewis, (“President”) is for cash advances made by the
President to Halltees for operating needs.  There is no set advance
maximum and funding of the advances is at the discretion of the
President.  The monies are advances and expected to be repaid when
cash-flow dictates.  There is no specified date for repayment and no
interest accrues.

    


    Any
amendments to this agreement must be approved by both parties in
writing.

    


    


    /s/
William Lewis

    _______________________________

    Hall
Tees, Inc.

    By
William Lewis, President

    


    


    /s/
William Lewis

    _______________________________

    William
Lewis
Page 1 of 3

Disposition Comments

Docket No: FAA-2011-1063 These comments are in

Directorate ID: 2011-NM-080 response to an SNPRM

Originating Office Tracking No.: 

Next Step: FRAN SNPRM

 No Comments/Only Supportive Comments Received – If this box is checked, no signatures are 

required.

No Has the referenced service information been revised since the NPRM was issued? If yes, 

list latest revision and attach a copy. Note that changes beyond the scope of the previously 

published NPRM will require a new notice. Contact the Directorate focal point for guidance.

Instructions: Summarize all comments by issue (not by commenter) and provide your recommended resolution of 

each issue. All comments relating to the same issue should be discussed together. Do not list all of the issues 

from one commenter together. If changes to the AD are required based on the comments received, explain why and 

describe in detail what change(s) you recommend. Reference FAA-IR-M-8040.1C Chapter 9.

ISSUE 1: Select one of the following: 

If other, explain: 

Commenter(s): 

What change to the AD action is requested? 

Why is the change requested or how is it justified? 

Do we agree? 

If YES, we agree because Make the following changes to the AD: 

If PARTIALLY AGREE, we agree with because We disagree with because 

Make the following changes to the AD: 

If NO, we don’t agree because 

ISSUE 2: Select one of the following: 

If other, explain: 

Commenter(s): 

What change to the AD action is requested? 

Why is the change requested or how is it justified? 

Do we agree? 

If YES, we agree because Make the following changes to the AD: 

If PARTIALLY AGREE, we agree with because We disagree with because 

Make the following changes to the AD:
Page 2 of 3

If NO, we don’t agree because 

For additional issues, double-click here
Page 3 of 3

Signature Section

Signature indicates concurrence with this action.

Originating Office Tracking No.: 

ASE Printed Name: Date

Branch Manager Date
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[S. 1861 Placed on Calendar Senate (PCS)]

                                                       Calendar No. 164
114th CONGRESS
  1st Session
                                S. 1861

    To prohibit Federal funding of Planned Parenthood Federation of 
                                America.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             July 24, 2015

 Mr. Paul introduced the following bill; which was read the first time

                             July 26, 2015

            Read the second time and placed on the calendar

_______________________________________________________________________

                                 A BILL

 
    To prohibit Federal funding of Planned Parenthood Federation of 
                                America.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PROHIBITION.

    Notwithstanding any other provision of law, no Federal funds may be 
made available to Planned Parenthood Federation of America, or to any 
of its affiliates.
                                                       Calendar No. 164

114th CONGRESS

  1st Session

                                S. 1861

_______________________________________________________________________

                                 A BILL

    To prohibit Federal funding of Planned Parenthood Federation of 
                                America.

_______________________________________________________________________

                             July 26, 2015

            Read the second time and placed on the calendar
```
Fourth Court of Appeals

San Antonio, Texas

January 23, 2020

No. 04-19-00786-CV

IN THE INTEREST OF P.M.M.K.,

From the 408th Judicial District Court, Bexar County, Texas

Trial Court No. 2018-PA-00915

Honorable Charles E. Montemayor, Judge Presiding

O R D E R

This is an accelerated appeal of an order terminating the appellant’s parental rights which 

must be disposed of by this court within 180 days of the date the notice of appeal is filed. TEX. 

R. JUD. ADMIN. 6.2.

The appellant’s brief was originally due to be filed on December 11,2019. We previously 

granted appellant an extension of time in which to file appellant’s brief, extending the due date to 

January 9, 2020. Appellant requests an extension of twenty days in which to file appellant’s 

brief. The motion is GRANTED. It is ORDERED that appellant’s brief must be filed in this 

appeal on or before January 29, 2020. Given the disposition deadline for this appeal, further 

extensions of time in which to file appellant’s brief will be disfavored.

_________________________________

Irene Rios, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 23rd day of January, 2020.

___________________________________

MICHAEL A. CRUZ,

Clerk of Court
<PAGE>

                                                                    Exhibit 99.1


                                 ePresence, Inc.
                                120 Flanders Road
                             Westboro, MA 01581-5013



                                 March 29, 2002

VIA EDGAR
---------

Securities and Exchange Commission
Judiciary Plaza
450 Fifth Street., N.W.
Washington, D.C. 20549

Dear Sir or Madam:

     In accordance with Temporary Note 3T to Article 3 of Regulation S-X,
ePresence, Inc. (the "Company") hereby confirms that Arthur Andersen LLP
("Andersen") has represented to the Company that the audit with respect to which
Andersen's report included in the Form 10-K filed herewith applies was subject
to Andersen's quality control system for the U.S. accounting and auditing
practice to provide reasonable assurance that the engagement was conducted in
compliance with professional standards and that there was appropriate continuity
of Andersen personnel working on audits, availability of national office
consultation and availability of personnel at foreign affiliates of Andersen is
not relevant to this audit.

                                   Sincerely,

                                   ePresence, Inc.


                                   By: /s/ Richard M. Spaulding
                                      -------------------------------
                                       Chief Financial Officer
#### Dougherty and wife, Appellants, vs. Wm. H. Shenners Company, Respondent.

For the appellants: Brei'i~nan, Lucas & McDonough of Milwaukee.

For the respondent: Edgar L. Wood of Milwaukee.

By the Court. Judgment affirmed.
Notice of Termination for GI Products received from Glaxo Group Limited



 EXHIBIT 10.5 
 VIA FACSIMILE AND 
 OVERNIGHT MAIL 
 August 29,
2008 
 Michael R. Dougherty 
 President and Chief Executive
Officer 
 Adolor Corporation 
 700 Pennsylvania Drive 

Exton, Pennsylvania 19341 
  

	Re:	Notice of Termination for GI Products 

 Dear Mike, 
 This Notice of Termination (“Notice”) is in reference to the Collaboration Agreement dated April 14, 2002 (the “Collaboration Agreement”), as
amended by Amendment No. 1 to the Collaboration Agreement effective on June 24, 2003 (“Amendment No. 1”), Amendment No.2 to the Collaboration Agreement effective on December 22, 2004 (“Amendment No. 2”)
and Amendment No. 3 to the Collaboration Agreement effective on June 9, 2008 (“Amendment No. 3”) (the Collaboration Agreement, Amendment No. 1, Amendment No.2 and Amendment No. 3 are collectively referred to herein
as, the “Agreement”), by and between Adolor Corporation (“Adolor”) and Glaxo Group Limited (“GGL”). All capitalized terms used in this Notice that are not otherwise defined herein shall have the meanings given to them
in the Agreement. 
 Pursuant to Section 16.6.3(a) of the Agreement, GSK is hereby terminating the Agreement with respect to the OBD Chronic Product in
the United States and the ROW as of the date of this Notice. Further, pursuant to Section 16.7.1 of the Agreement, GSK is hereby terminating the Agreement with respect to the IBS Product and the Constipation Product in the United States and the
ROW as of the date of this Notice. 
 In furtherance of Section 16.12.1 of the Agreement, GSK has commenced activities to effectuate the transfer of
Investigational New Drug (IND) Application 66,087 to Adolor, including verbally notifying the FDA on August 28, 2008 of GSK’s intention to transfer this IND. 
 Please do not hesitate to contact Vinod Ramachandran if you have any questions. 
 Very truly yours, 
 GLAXO GROUP LIMITED 
  

			
	 By:
	 	 /s/    V.A. Whyte

	 Name:
	 	 V.A. Whyte

	 Title:
	 	 Assistant Secretary









 Michael R. Dougherty 
 Page 2

  

	cc:	Randall B. Sunberg, Esq. 

 Ad Rawcliffe 
 Anne Whitaker 
 David Chang 
 Letizia Amadini-Lane 
 Vinod Ramachandran

 Carol Ashe 
 Hope
D’Oyley-Gay, Esq.
exv10w10w6






Exhibit 10.1.6




AMENDMENT

TO THE WESTERN DIGITAL 401(k) PLAN



The Western Digital Corporation 401(k) Plan (hereinafter referred to as the “Plan”) is hereby
amended effective September 1, 2008.



WHEREAS, Western Digital Corporation believes that participation by employees in the Plan at a
salary deferral level that provides greater access to the Company’s matching contribution is
beneficial to those employees and desires to amend the Plan to facilitate such greater access to
the Company’s matching contribution through automatic enrollment;



NOW, THEREFORE, the Plan is hereby amended as follows:




Amendment





Section 2.33 of the Plan is hereby amended to provide that the default salary or wage
deferral for an Eligible Employee who is automatically enrolled in the Plan shall be 5% of
the Eligible Employee’s Compensation instead of 3% of the Eligible Employee’s Compensation.


IN WITNESS WHEREOF, and as evidence of its adoption of this Amendment to the Plan, Western Digital
Corporation has caused this Amendment to be executed by its duly authorized officer.




	 	 	 	 	 
	Western Digital Corporation	 	 
	 
	 	 	 	 
	By:

	 	/s/ Jackie DeMaria
 

	 	 
	Print Name:

	 	Jackie DeMaria	 	 
	Title:

	 	Vice President, Human Resources	 	 
	Date:

	 	8/14/08
# CE2004084EN.01070301.xml

| 3.4.2004 | EN | Official Journal of the European Union | CE 84/703 |
| --- | --- | --- | --- |

3.4.2004

EN

Official Journal of the European Union

CE 84/703

---

(2004/C 84 E/0789)

WRITTEN QUESTION P-1040/04

by Enrico Ferri (PPE-DE) to the Commission

(29 March 2004)

Subject:   Requirements for entry in the studbook, transposition of Community legislation

Subject:

Further to my parliamentary question of 27 October 2003 and the Commission's answer (P-3312/03 (1)), it is important to point out that the question concerns a matter falling within the sphere of competence not only of DG SANCO but also of DG MARKT, in addition to the fact that the Commission has merely replied that it was not aware of the problem and has not expressed its views on the substance of the matter.

1

Will the Commission, represented by Commissioner Byrne and Commissioner Bolkestein, indicate what steps have been taken to check whether the Community legislation relating to the sector has been properly and adequately transposed?

Has the Commission checked whether the existence of the assessment committee which I referred to is admissible?

Answer given by Mr Byrne on behalf of the Commission

(23 April 2004)

(23 April 2004)

The Commission would like to reassure the Honourable Member that it followed up the information he provided in Written Question P-3312/03 of 27 October 2003.

As indicated in its answer, the Commission had no knowledge of the existence in Italy of a morphological test for entering stallions in the studbook and a committee to carry out the assessment.

However, following the written question, the Commission decided to open an own-initiative investigation, registered as No 2004/2069, in order to clarify the facts and draw the appropriate conclusions.

The investigation is being carried out by the Directorate-General for Health and Consumer Protection, which is the service responsible for Directive 90/427/EC (2) on the zootechnical and genealogical conditions governing intra-Community trade in equidae.

2

A letter was sent to the Italian authorities on 31 March 2004 asking for confirmation of the existence of this test and requesting a copy of the relevant national legislation.

---

(1)  OJ C 70 E, 20.3.2004, p. 254.

1

(2)  Council Directive 90/427/EEC of 26 June 1990 on the zootechnical and genealogical conditions governing intra-Community trade in equidae, OJ L 224, 18.8.1990.

2

---